
Health Tidings
Generics
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Generics
GenericsDr. Reddy’s Wins FDA Approval for Generic Lenacapavir Across LMICsDr. Reddy’s Laboratories has secured tentative FDA approval for its generic twice-yearly injectable lenacapavir for HIV prevention.Fact-Checked
GenericsZydus Gains FDA Approval for Weekly Menopause Hormone TherapyThe FDA has approved Zydus Pharmaceuticals’ first generic version of Climara Pro, a once-weekly estradiol and levonorgestrel patch for treating moderate-to-severe menopausal vasomotor symptoms and preventing postmenopausal osteoporosis…Fact-Checked
GenericsFDA Approves Alcon’s Brytly Eye Drops for Redness ReliefThe FDA has approved Alcon’s Brytly (apraclonidine ophthalmic solution 0.125%) for temporary relief of eye redness caused by minor irritations.Fact-Checked
GenericsLupin Launches Formoflo-G MDI in India for COPD Triple TherapyLupin has launched Formoflo-G MDI in India, a fixed-dose triple-combination inhaler containing glycopyrronium bromide, formoterol fumarate and fluticasone propionate for the long-term management of moderate to severe COPD.Fact-Checked
GenericsTeva’s DEGEVMA Receives U.S. FDA Approval as Biosimilar to XgevaTeva’s DEGEVMA (denosumab-adet) has received FDA approval as a biosimilar to Xgeva, covering its approved indications and becoming Teva’s second FDA-approved biosimilar of 2026.Fact-Checked
GenericsLupin Secures U.S. FDA Tentative Approval for Apixaban Oral SuspensionLupin has received tentative U.S. FDA approval for apixaban oral suspension 1.25 mg/mL under the 505(b)(2) pathway, providing a potential liquid administration option for adults requiring anticoagulation who…Fact-Checked
GenericsLupin Secures U.S. FDA Approval for Generic Modafinil Tablets (100 mg and 200 mg)Lupin has received U.S. FDA approval for Modafinil Tablets USP 100 mg and 200 mg, bioequivalent to Provigil, for improving wakefulness in adults with excessive sleepiness associated with…Fact-Checked
GenericsZydus Secures USFDA Approval for Ascorbic Acid Injection for ScurvyZydus Lifesciences has received USFDA approval for Ascorbic Acid Injection USP, a generic intravenous vitamin C treatment for scurvy in adults and pediatric patients aged 5 months and…Fact-Checked
GenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal SprayGlenmark Pharmaceuticals has received U.S. FDA approval for Fluticasone Propionate Nasal Spray USP 0.05 mg/spray, a product bioequivalent and therapeutically equivalent to Flonase Nasal Spray.Fact-Checked
GenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled AutoinjectorBiocon Limited has secured supplemental US FDA approval for single-dose prefilled autoinjector options of YESINTEK® (ustekinumab-kfce).Fact-Checked
GenericsZydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-day CGT exclusivityZydus Lifesciences has received USFDA approval for its generic Indocyanine Green for Injection, USP, 25 mg/vial.Fact-Checked
GenericsFDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with DiabetesThe U.S. FDA has approved Garzulys (insulin aspart-fsan), a rapid-acting biosimilar to NovoLog, for improving glycemic control in adults and pediatric patients with diabetes mellitus.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.